Importantly, cGMP–PKG activation with sGC stimulation stimulates angiogenesis in such oestrogen-deficient hearts and ameliorates heart failure, which might form an additional mechanistic basis for the therapeutic use of sGC stimulators. Here, PRKG1 is linked to heart failure.